CCC
FBRX

Cable Car Capital’s Forte Biosciences FBRX Stock Holding History

Cable Car Capital’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Hold
400,000
– – 0.18% 54
2026
Q1 		$10.4M Hold
400,000
– – 3.58% 5
2025
Q4 		$10.9M Sell
400,000
-100,000
-20% -$1.75M 0.36% 19
2025
Q3 		$7.5M Hold
500,000
– – 3.21% 5
2025
Q2 		$6.46M Buy
500,000
+280,396
+128% +$2.41M 2.07% 6
2025
Q1 		$1.7M Hold
219,604
– – 1.93% 20
2024
Q4 		$4.99M Buy
219,604
+138,325
+170% +$1.65M 0.2% 42
2024
Q3 		$454K Hold
81,279
– – 0.49% 38
2024
Q2 		$1.09M Hold
81,279
– – 1.15% 24
2024
Q1 		$1.41M Hold
81,279
– – 1.95% 19
2023
Q4 		$1.67M Buy
+81,279
New +$1.14M 1.73% 17

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Cable Car Capital's FBRX Position: Q2 2026 in Review

Cable Car Capital held its Forte Biosciences (FBRX) position steady in Q2 2026 at 400,000 shares worth $8.5M. The position accounts for 0.18% of the portfolio, ranked #54.

Cable Car Capital first reported a position in FBRX in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.9M in Q4 2025. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Cable Car Capital held 400,000 shares of Forte Biosciences worth $8.5M as of Q2 2026.
  • Cable Car Capital left its Forte Biosciences share count unchanged in Q2 2026.
  • Forte Biosciences made up 0.18% of Cable Car Capital's portfolio in Q2 2026, its #54 holding.
  • Cable Car Capital first reported a position in Forte Biosciences in Q4 2023 and has held it in 11 quarters since.
  • Cable Car Capital's Forte Biosciences position peaked at $10.9M in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Cable Car Capital's 13F filing for Q2 2026, filed 14 Aug 2026.